Cargando…

Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review

This review provides a broad summary of the performance characteristics of high-throughput severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic assays with Food and Drug Administration Emergency Use Authorization, which are commonly found in central clinical laboratories. In additi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Theel, Elitza S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563341/ https://www.ncbi.nlm.nih.gov/pubmed/35153046 http://dx.doi.org/10.1016/j.cll.2021.10.006

Ejemplares similares

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021)

753. Performance Characteristics of Diagnostic Assays in Blastomycosis
por: O’Dowd, Timothy, et al.
Publicado: (2020)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

Serological assays for emerging coronaviruses: Challenges and pitfalls
por: Meyer, Benjamin, et al.
Publicado: (2014)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
por: Trombetta, Bianca A., et al.
Publicado: (2021)

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area
por: Shah, Vishal P., et al.
Publicado: (2020)

Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
por: Harvey, Ruth, et al.
Publicado: (2019)

Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
por: Trombetta, Bianca A., et al.
Publicado: (2021)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
por: Perera, Ranawaka APM, et al.
Publicado: (2020)

Multiplexed High-Throughput Serological Assay for Human Enteroviruses
por: Saarinen, Niila V. V., et al.
Publicado: (2020)

Evaluation of the genalyte maverick SARS-CoV-2 multi-antigen serology panel
por: Donato, Leslie J., et al.
Publicado: (2021)

Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports
por: Emeribe, Anthony Uchenna, et al.
Publicado: (2021)

Serological prevalence of canine respiratory coronavirus
por: Priestnall, Simon L., et al.
Publicado: (2006)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
por: Ochola, Lucy, et al.
Publicado: (2022)

A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2
por: Weiss, Svenja, et al.
Publicado: (2020)

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients
por: Choi, Hyun-Woo, et al.
Publicado: (2022)

Validation of high-throughput, semiquantitative solid phase SARS coronavirus-2 serology assays in serum and dried blood spot matrices
por: Maritz, Leo, et al.
Publicado: (2021)

Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning
por: Pecora, Nicole D., et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates
por: Kubiak, Jeffrey M., et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing – A Laboratory Primer
por: Slev, Patricia R.
Publicado: (2022)

Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests
por: Nishimura, Masashi, et al.
Publicado: (2022)

Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017
por: Theel, Elitza S, et al.
Publicado: (2020)

Validation of laboratory developed serology assays for detection of IgG antibody to severe acute respiratory syndrome coronavirus 2 in the South African population
por: Matefo, Litabe, et al.
Publicado: (2022)

Trends in Q fever serologic testing by immunofluorescence from four large reference laboratories in the United States, 2012–2016
por: Miller, Halie K., et al.
Publicado: (2018)

Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
por: Larkey, Nicholas E., et al.
Publicado: (2022)

A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients
por: Liu, Lei, et al.
Publicado: (2020)

Clinical characteristics of subjects with lack of seroconversion following COVID-19 vaccination
por: Ahluwalia, Vaibhav, et al.
Publicado: (2022)

Serological assays and host antibody detection in coronavirus-related disease diagnosis
por: Dowlatshahi, Sayeh, et al.
Publicado: (2021)

Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan
por: Hsueh, Po-Ren, et al.
Publicado: (2003)

Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries
por: Hashmi, Shahrukh K., et al.
Publicado: (2020)

339. Assessing Utilization of the Venereal Disease Research Laboratory Test in Cerebrospinal Fluid for the Diagnosis of Neurosyphilis: A Cohort Study
por: Sytsma, Terin, et al.
Publicado: (2020)

Serological and molecular evidence that canine respiratory coronavirus is circulating in Italy
por: Decaro, Nicola, et al.
Publicado: (2007)

Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
por: Carreño, Juan Manuel, et al.
Publicado: (2021)

Why Do We Need Serological Tests for Severe Acute Respiratory Syndrome Coronavirus-2 Diagnosis?
por: Ghazi, Bouchra, et al.
Publicado: (2020)

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration
por: Fiedler, Sebastian, et al.
Publicado: (2022)

Evaluation of the Serologic Cross-Reactivity between Transmissible Gastroenteritis Coronavirus and Porcine Respiratory Coronavirus Using Commercial Blocking Enzyme-Linked Immunosorbent Assay Kits
por: Magtoto, Ronaldo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p66vdr2l4s5knf6vm8jl7b8rba